ACROFAN

Wednesday, September 18, 2024

- General
- Aerospace/Defense
- Logistics/Transport
- Construction/Build
- Energy
- Machine
- Material
- Bio/Medical
- Food
- Beauty
- Fashion
- Infant
- General
- Policy
- Finance
- Stock
- RealEstate
- Startup
- Franchise
- Retail
- Overseas
- Computer
- Mobile
- Device
- Component
- Enterprise
- Carrier
- Internet
- Security
- Review
- Information
- PC
- Console
- Mobile
- eSports
- Development
- Review
- Information
- Automobile
- Automotive
- After Market
- Car Culture
- Traffic
- Review
- Information
- Broadcast
- Entertainment
- Movie
- Music
- K-Wave
- Review
- Information
- General
- Assembly
- Court
- Government
- Education
- Science
- Environment
- Employment
- Welfare
- Media
- Social Contribution
- Opinion
- General
- Travel
- Leisure
- Restaurants
- Festival
- Event
- Local Area
- International
- Book
- Religion
- Health
- Sports

Industry	Economy	TECH	GAME	AUTO	MEDIA	Society	Comfort	Theme	Photo	Media	Publish
General Aerospace/Defense Logistics/Transport Construction/Build Energy Machine Material Bio/Medical Food Beauty Fashion Infant	General Policy Finance Stock RealEstate Startup Franchise Retail Overseas	Computer Mobile Device Component Enterprise Carrier Internet Security Review Information	PC Console Mobile eSports Development Review Information	Automobile Automotive After Market Car Culture Traffic Review Information	Broadcast Entertainment Movie Music K-Wave Review Information	General Assembly Court Government Education Science Environment Employment Welfare Media Social Contribution Opinion	General Travel Leisure Restaurants Festival Event Local Area International Book Religion Health Sports	Theme	Photo	Media	Publish

Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Des

ISM001-055 is a novel drug designed in-house using generative AI to target TNIK (Traf2- and NCK- interacting kinase) and has progressed through Phase IIa clinical testing. Preliminary results from this 12-week study demonstrated that I..

Wednesday, September 18, 2024, 9:30 pm

Alef signs mass manufacturing flying car agreement

Alef Aeronautics signs a manufacturing agreement with PUCARA Aero and MYC for aviation grade parts for its 3,200 pre-orders PUCARA Aero and MYC, a joint venture with experience manufacturing aviation grade parts f..

Wednesday, September 18, 2024, 9:17 pm

Bloomage 2024 Mid-Year Report: Driving Growth Through Strategic Transformation to a Solutions Provider

PARSIPPANY, N.J., Sept. 18, 2024 /PRNewswire/ -- On August 23, 2024, Bloomage released its mid-year financial report, reporting a revenue of RMB 2.811 billion (~USD 385 million) for the first half of the year. This success reflects the comp..